Keywords: roche, pegasys, effective, treating, most, difficult-to-treat, form

Roche's Pegasys effective in treating most difficult-to-treat form of HBV

Article | 27 September 2004

Print This

Findings published in the New England Journal of Medicine suggest that Roche's Pegasys (peginterferon alfa-2a) is more effective in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in